Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Diagnosis
874 results:

  • 1. Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?
    Agatsuma N; Utsumi T; Nishikawa Y; Horimatsu T; Seta T; Yamashita Y; Tanaka Y; Inoue T; Nakanishi Y; Shimizu T; Ohno M; Fukushima A; Nakayama T; Seno H
    World J Gastroenterol; 2024 Mar; 30(10):1368-1376. PubMed ID: 38596494
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A proteomic classifier panel for early screening of colorectal cancer: a case control study.
    Hua H; Wang T; Pan L; Du X; Xia T; Fa Z; Gu L; Gao F; Yu C; Gao F; Liao L; Shen Z
    J Transl Med; 2024 Feb; 22(1):188. PubMed ID: 38383428
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pan-cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours.
    Chen Y; Gao Z; Mohd-Ibrahim I; Yang H; Wu L; Fu Y; Deng Y
    Clin Transl Med; 2024 Feb; 14(2):e1543. PubMed ID: 38303608
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genotype-phenotype correlations in carriers of the pms2 founder variant c.1831dup.
    Gass M; Seebauer B; Thommen A; Fischler A; Heinimann K
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2360. PubMed ID: 38284451
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort.
    Iams WT; Mackay M; Ben-Shachar R; Drews J; Manghnani K; Hockenberry AJ; Cristofanilli M; Nimeiri H; Guinney J; Benson AB
    JAMA Netw Open; 2024 Jan; 7(1):e2351700. PubMed ID: 38252441
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patient-Reported Financial Burden of Treatment for Colon or Rectal cancer.
    Kircher S; Duan F; An N; Gareen IF; Sicks JD; Sadigh G; Suga JM; Kehn H; Mehan PT; Bajaj R; Hanson DS; Dalia SM; Acoba JD; Yasar DG; Park ER; Wagner LI; Carlos RC
    JAMA Netw Open; 2024 Jan; 7(1):e2350844. PubMed ID: 38194233
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prolonged preoperative sedentary time is a risk factor for postoperative ileus in patients with colorectal cancer: a propensity score-matched retrospective study.
    Yanagisawa T; Tatematsu N; Horiuchi M; Migitaka S; Yasuda S; Itatsu K; Kubota T; Sugiura H
    Support Care Cancer; 2023 Dec; 32(1):54. PubMed ID: 38129532
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MLH1 Promotor Hypermethylation in colorectal and Endometrial Carcinomas from Patients with Lynch Syndrome.
    Helderman NC; Andini KD; van Leerdam ME; van Hest LP; Hoekman DR; Ahadova A; Bajwa-Ten Broeke SW; Bosse T; van der Logt EMJ; Imhann F; Kloor M; Langers AMJ; Smit VTHBM; Terlouw D; van Wezel T; Morreau H; Nielsen M
    J Mol Diagn; 2024 Feb; 26(2):106-114. PubMed ID: 38061582
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
    Li M; Zheng W
    Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Disparities among Black and Hispanic colorectal cancer patients: Findings from the California cancer Registry.
    Mendez JS; Wang R; Liu L; Zhang J; Schmitt SL; Figueiredo J; Lenz HJ; Stern MC
    Cancer Med; 2023 Nov; 12(22):20976-20988. PubMed ID: 37909220
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Province-Wide Ascertainment of Lynch Syndrome in Manitoba.
    Rothenmund H; Lambert P; Khan D; Kim C; Sharma B; Serfas K; Chodirker B; Singh H
    Clin Gastroenterol Hepatol; 2024 Mar; 22(3):642-652.e2. PubMed ID: 37879520
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study.
    Eikenboom EL; Moen S; van Leerdam ME; Papageorgiou G; Doukas M; Tanis PJ; Dekker E; Wagner A; Spaander MCW;
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1106-1117. PubMed ID: 37865103
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
    Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
    [No Abstract]    [Full Text] [Related]  

  • 15. Comparison of Methods for Testing Mismatch Repair Status in Endometrial cancer.
    Mendiola M; Heredia-Soto V; Ruz-Caracuel I; Baillo A; Ramon-Patino JL; Escudero FJ; Miguel M; Pelaez-Garcia A; Hernandez A; Feliu J; Hardisson D; Redondo A
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833916
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency.
    Guerrini-Rousseau L; Pasmant E; Muleris M; Abbou S; Adam-De-Beaumais T; Brugieres L; Cabaret O; Colas C; Cotteret S; Decq P; Dufour C; Guillerm E; Rouleau E; Varlet P; Zili S; Vidaud D; Grill J
    J Med Genet; 2024 Jan; 61(2):158-162. PubMed ID: 37775264
    [TBL] [Abstract] [Full Text] [Related]  

  • 18.
    Tobi M; Weinstein D; Kim M; Hatfield J; Sochacki P; Levi E; An T; Hamre M; Tolia V; Fligiel S; Marepally R; Hallman J; Bapat B; Yuan M; McVicker B; Gallinger S
    Curr Oncol; 2023 Aug; 30(9):7950-7963. PubMed ID: 37754493
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
    Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
    Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
    Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
    J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
    [TBL] [Abstract] [Full Text] [Related]  


    of 44.